atipamezole has been researched along with Acute Kidney Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Hei, Z; Huang, P; Ji, H; Qiu, R; Sha, W; Wang, F; Yao, W; Yuan, D | 1 |
| Chen, Q; Gu, J; Lu, K; Ma, D; Ma, J; Ning, J; Wu, L; Yi, B | 1 |
2 other study(ies) available for atipamezole and Acute Kidney Injury
| Article | Year |
|---|---|
Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Cecal Diseases; Cecum; Cytokines; Dexmedetomidine; Imidazoles; Inflammation; Kidney; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sepsis; Toll-Like Receptor 4 | 2018 |
α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
Topics: Actins; Acute Kidney Injury; Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antigens, CD; Cadherins; Capillary Permeability; Cells, Cultured; Dexmedetomidine; Disease Models, Animal; Endothelial Cells; Endothelium; Focal Adhesion Kinase 1; Humans; Imidazoles; Kidney; Lung; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Signal Transduction | 2016 |